Viewing nowNelson Pregabalin Capsule 150 mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
Korea Nelson Pharmaceutical Co., Ltd.

MFDS item code 201603533 · Approved 2016.06.16 · Insurance code 665506870
Treatment of neuropathic pain and partial seizures; treatment of fibromyalgia
This medication is effective in treating peripheral and central neuropathic pain in adults, assisting in the management of partial seizures in epilepsy patients, and helps in the treatment of fibromyalgia. It is effective in improving symptoms related to various neurological disorders and pain.
This medicine is administered orally, with or without food, in 2 divided doses of the total daily dose of pregabalin. Since this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: This medicine may be started at 150 mg daily. Based on the individual patient's response and tolerability, the dose may be increased to 300 mg daily after 3 to 7 days. If necessary, it may then be increased at 7-day intervals to a maximum of 600 mg daily. 2) Central neuropathic pain Adults: This medicine may be started at 150 mg daily. Based on the individual patient's response and tolerability, the dose may be increased to 300 mg daily after 1 week. After an additional 1 week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation’) 2. Epilepsy Adults: This medicine may be started at 150 mg daily. Based on the individual patient's response and tolerability, the dose may be increased to 300 mg daily after 1 week. If necessary, it may then be increased at 7-day intervals to a maximum of 600 mg daily. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg daily. The starting dose is 75 mg twice daily (150 mg daily); based on efficacy and tolerability, this may be increased within 1 week to 150 mg twice daily (300 mg daily). For patients who do not experience sufficient benefit at a dose of 300 mg daily, the dose may be increased within 1 week to 225 mg twice daily (450 mg daily). Clinical studies have also been conducted at a dose of 600 mg daily, but there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg daily are not recommended. 4. Discontinuation Based on current clinical experience, if treatment with this medicine is discontinued, it should be withdrawn gradually over at least 1 week. 5. Patients with renal impairment Creatinine clearance ≥60: starting dose 150 mg/day, maximum dose 600 mg/day, BID or TID Creatinine clearance ≥30 -<60: starting dose 75 mg/day, maximum dose 300 mg/day, BID or TID Creatinine clearance ≥15 -<30: starting dose 25-50 mg/day, maximum dose 150 mg/day, QD or BID Creatinine clearance <15: starting dose 25 mg/day, maximum dose 75 mg/day, QD Supplemental dose after hemodialysis: 25 mg, 100 mg, single dose TID = total daily dose administered in 3 divided doses BID = total daily dose administered in 2 divided doses QD = administered once daily a: The total daily dose (mg/day) should be administered in divided doses as specified in the dosing regimen. b: Supplemental dose refers to a dose administered as a single additional dose. 6. Patients with hepatic impairment No dosage adjustment is necessary in patients with hepatic impairment. 8. Older adults (65 years of age and older) Dose reduction may be necessary in older adults with impaired renal function.
Children under 12 years of age: Administration is not recommended because there are insufficient safety and efficacy data. Adolescent patients aged 12 ~17 years: Administration is not recommended because there are insufficient safety and efficacy data.
This medication is an anticonvulsant, and there is an increased risk of thoughts or actions of suicide during treatment, so immediate consultation with a healthcare provider is necessary if symptoms of depression or mood changes occur. Patients with hypersensitivity to this medication or those with genetic lactose metabolism disorders should not take it. Diabetic patients may need dose adjustments of blood sugar control medications due to weight gain while taking this medication. If symptoms of angioedema occur, the medication should be discontinued immediately, and caution is required for the elderly due to the risk of falls from dizziness or drowsiness. Visual disturbances such as blurred vision may occur, so any abnormalities should be reported to a healthcare provider. Discontinuing this medication suddenly may result in withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so it is advisable to taper off the dose gradually. Patients with a history of substance abuse should exercise caution due to the potential for misuse or dependence on this medication. Patients with reduced kidney function require dose adjustments, and those with heart disease should also use this medication cautiously. Combining this medication with opioid analgesics may increase the risk of central nervous system depression, so caution should be exercised. In early pregnancy, there is a risk of fetal malformation, so pregnant women should not take this medication, and women of childbearing potential should use effective birth control while on this medication. Breastfeeding mothers are advised to either stop nursing or discontinue this medication since it can pass into breast milk. Patients should check whether this medication causes dizziness or drowsiness before driving or operating machinery and should avoid dangerous activities if symptoms are present. Severe skin reactions can rarely occur, so if symptoms such as rash or swelling appear, discontinue use immediately and consult a healthcare provider. In case of overdose, symptoms may include drowsiness, confusion, and depression, and treatment such as blood dialysis may be necessary.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture, at room temperature between 15 and 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness for a longer period.
A firm capsule with a white powder that is white or light yellow in color.
30 capsules/bottle, 60 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
Korea Nelson Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.